What is Triploidy

Triploidy is a rare and severe chromosomal abnormality in which an individual has three complete sets of chromosomes (69 chromosomes) instead of the usual two (46 chromosomes). Because this condition affects the genetic blueprint of nearly every cell in the developing fetus, it is generally incompatible with long-term survival, typically resulting in miscarriage or neonatal loss.

What causes Triploidy and how does it occur?

In most human cells, we inherit 23 chromosomes from each parent for a total of 46. Triploidy occurs when an error during fertilization results in an extra set of chromosomes. This usually happens through dispermy (two sperm fertilizing one egg) or the failure of a cell to divide properly during egg or sperm formation. Unlike conditions like Down syndrome, where only one specific chromosome is duplicated, Triploidy involves the duplication of the entire genome.

Which body systems are affected by Triploidy?

Because Triploidy affects every cell, the impact is systemic and profound, leading to significant structural abnormalities during fetal development. Common clinical findings include:

• Severe intrauterine growth restriction (IUGR).


• Central nervous system malformations, such as holoprosencephaly or hydrocephalus.


• Distinctive facial features, including low-set ears and micrognathia (small jaw).


• Congenital heart defects and structural anomalies in the kidneys.


• Placental abnormalities, such as cystic changes or hydatidiform mole.

How common is Triploidy?

Triploidy is estimated to occur in 1% to 2% of all recognized pregnancies, though it is far more common in early miscarriages, where it accounts for approximately 15% to 20% of cases involving chromosomal abnormalities. The condition does not favor any specific geographic region or ethnicity, and it affects both male and female fetuses. Within the DiseaseMaps.org community, 33 individuals have connected to share experiences related to this diagnosis.

How is Triploidy differentiated from other conditions?

Triploidy is distinct from trisomy (where only one extra chromosome is present, such as in Trisomy 21). The primary differentiator is the total number of chromosomes—69 in Triploidy versus 47 in common trisomies. Additionally, the presence of specific placental changes often helps clinicians differentiate Triploidy from other chromosomal disorders during prenatal screening.

Next steps

• Consult with a board-certified genetic counselor to discuss recurrence risks and genetic testing.


• Speak with a maternal-fetal medicine (MFM) specialist for a detailed review of prenatal findings.


• Connect with the 33 members of the DiseaseMaps community who have experience navigating this diagnosis.


• Seek support from bereavement counselors or specialized support groups if you are processing a pregnancy loss.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• National Institutes of Health (NIH) GARD: Triploidy.


• Orphanet: Triploidy (ORPHA:96144).


• Online Mendelian Inheritance in Man (OMIM): Triploidy.


• American College of Obstetricians and Gynecologists (ACOG) practice bulletins on prenatal genetic screening.